ALICE CARTER: Open Payments
NPI 1407490097 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 117 payments from 15 companies in 2025. Trend: 2023 $210 · 2024 $1,346 · 2025 $2,322
Food & beverage: $2,322
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $516 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $307 |
| Janssen Biotech, Inc. | 18 | $269 |
| Madrigal Pharmaceuticals | 14 | $251 |
| Lilly USA, LLC | 10 | $198 |
| Regeneron Healthcare Solutions, Inc. | 2 | $142 |
| GENZYME CORPORATION | 6 | $137 |
| QOL Medical, LLC | 4 | $109 |
| Ardelyx, Inc. | 6 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
Products named: DUPIXENT, TREMFYA, REZDIFFRA, RINVOQ, ENTYVIO, OMVOH, SKYRIZI, Sucraid.
Industry payments across FL — which companies pay providers there.
